Dated proof you called it early
Your name, reason, and the date stay on this page and on your profile, ready to send to anyone.
Startup
Insilico Medicine
Transforming drug discovery with AI.
Nobody has vouched for Insilico Medicine yet
The first person to vouch is the scout. Everyone after adds their name and their reason.
Scouted by
Nobody yet
The first person to vouch for Insilico Medicine is its scout, and that stays on the record.
Vouched by
Open. Vouches appear here in the order they were made.
Believe in Insilico Medicine? Be its scout.
One reason, in your own words. It takes about two minutes.
Vouch for Insilico MedicineWhat vouching gets you
The founders are told
They get your name and your reason, and can write back to you.
Coming soonYou may be invited in
If Insilico Medicine raises here, people who vouched may be invited to take part. Earlier vouches first.
Coming soonWho believed, and when
Each vouch on one line, from the first one to today, and how those people know the startup.
No vouches yet. The line starts on the day of the first one.
Why people vouch
Each person says how they know the startup and why they believe in it.
No reasons yet
Reasons appear here in the words of the people who gave them, scout first.
From the founders
This page has not been claimed
When the founders of Insilico Medicine claim it with a work email, their names and their reply to the people who vouched appear here. Claiming is coming soon.
About Insilico Medicine
Insilico Medicine, founded in 2014, is a clinical-stage biotechnology company that specializes in drug discovery and development through its proprietary Pharma.AI platform. The company employs advanced generative AI and deep learning technologies to identify novel drug targets and expedite the development of therapies for diseases such as fibrosis, cancer, immunology, and aging-related conditions. Insilico's Pharma.AI platform includes various components, such as PandaOmics for target discovery, which enhances the efficiency and effectiveness of the drug development process.
More startups in Longevity
StartupOptimizing healthspan through preventive medicine.
StartupBiotechnology company targeting aging-related diseases.
StartupAeovian Pharmaceuticals develops selective mTORC1 inhibitors for rare and age-related diseases, led by AV078 for tuberous sclerosis complex.
StartupAgeX Therapeutics was a Michael West company developing induced tissue regeneration and cell therapies for age-related degenerative disease.
StartupAgelessRx is a telehealth provider of longevity prescriptions such as rapamycin and metformin that also sponsors decentralized longevity trials.
StartupAlkahest mines the plasma proteome for therapies and biomarkers of age-related disease, building on young-plasma research.
What you can do with Insilico Medicine
Two of these work today. The rest are on the way.
Vouch for Insilico MedicineSay why you believe in it. The first person to vouch is its scout, and that stays on the record.
Claim this page
Founders and team members confirm with a work email, then keep the page accurate.
Coming soonFollow Insilico Medicine
Get a note when it raises, launches, or joins a program.
Coming soonSend it to an investor
Pass it to investors who back this sector, with your reason attached.
Pro, coming soonAsk for an introduction
Reach the founders through someone who has vouched for them.
Coming soonIs this page right?How the research works